<![CDATA[Genmab β€” November 2017]]>God morgen. πŸ™‚

]]>https://dev.proinvestor.com/forum/topic/451512/genmab-november-2017RSS for NodeSun, 14 Jun 2026 05:37:58 GMTWed, 01 Nov 2017 04:16:13 GMT60<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:56:59 GMT]]>Thomas - partnere er vigtige for JNJ. Hvis du behandler
dem dΓ₯rligt bliver det svΓ¦rt at finde nye

]]>https://dev.proinvestor.com/forum/post/10164999https://dev.proinvestor.com/forum/post/10164999Thu, 30 Nov 2017 19:56:59 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:55:50 GMT]]>Hvis man bliver uvenner har man kontrakten πŸ™‚

]]>https://dev.proinvestor.com/forum/post/10164997https://dev.proinvestor.com/forum/post/10164997Thu, 30 Nov 2017 19:55:50 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:55:30 GMT]]>Gate gate gate ipad

]]>https://dev.proinvestor.com/forum/post/10165001https://dev.proinvestor.com/forum/post/10165001Thu, 30 Nov 2017 19:55:30 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:55:10 GMT]]>Hare Ipad

]]>https://dev.proinvestor.com/forum/post/10165000https://dev.proinvestor.com/forum/post/10165000Thu, 30 Nov 2017 19:55:10 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:54:52 GMT]]>Probably also a bad thing to give a discount om Dara in one combination - it will give payers duel to ask for discounts in other combinations

]]>https://dev.proinvestor.com/forum/post/10164995https://dev.proinvestor.com/forum/post/10164995Thu, 30 Nov 2017 19:54:52 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:51:26 GMT]]>Hvad har J&J at tabe ved at kΓΈre dirty business mod
Genmab? De har allerede aftalen pΓ₯ Dara og duobody locked up

]]>https://dev.proinvestor.com/forum/post/10164994https://dev.proinvestor.com/forum/post/10164994Thu, 30 Nov 2017 19:51:26 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:23:57 GMT]]>i mean, if you look at morphosys for example, suing JNJ on dara while at the same time they are also partner in other deals...it can be a dirty business....

]]>https://dev.proinvestor.com/forum/post/10164992https://dev.proinvestor.com/forum/post/10164992Thu, 30 Nov 2017 19:23:57 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:20:43 GMT]]>that i agree on Solson, and i would imagine JNJ is a respectable partner. But i have always thought pricing is the privilege of JNJ and always seen that as a risk, so any info that it is different would be welcome

]]>https://dev.proinvestor.com/forum/post/10164991https://dev.proinvestor.com/forum/post/10164991Thu, 30 Nov 2017 19:20:43 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:15:01 GMT]]>Exactly

]]>https://dev.proinvestor.com/forum/post/10164989https://dev.proinvestor.com/forum/post/10164989Thu, 30 Nov 2017 19:15:01 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 19:11:42 GMT]]>Which... and a partnership is not a matter of cheating each other.

]]>https://dev.proinvestor.com/forum/post/10164988https://dev.proinvestor.com/forum/post/10164988Thu, 30 Nov 2017 19:11:42 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 18:51:08 GMT]]>Iam sure they are not that stupid. There has to be a contract wich deal with that issue.

]]>https://dev.proinvestor.com/forum/post/10164998https://dev.proinvestor.com/forum/post/10164998Thu, 30 Nov 2017 18:51:08 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 18:28:17 GMT]]>dont think Genmab will have a choice really, do they? JNJ sets the price? Do you think they have a minimum price set in a contract or something?

]]>https://dev.proinvestor.com/forum/post/10164986https://dev.proinvestor.com/forum/post/10164986Thu, 30 Nov 2017 18:28:17 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 18:24:42 GMT]]>Dont think Genmab will approve that strategy.

]]>https://dev.proinvestor.com/forum/post/10164985https://dev.proinvestor.com/forum/post/10164985Thu, 30 Nov 2017 18:24:42 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 18:09:39 GMT]]>puts JNJ in a nice position if they get this approved, they can price the PD-1+dara combo competitively to win business, putting any discount on the dara part offcourse to save on royalty

]]>https://dev.proinvestor.com/forum/post/10164993https://dev.proinvestor.com/forum/post/10164993Thu, 30 Nov 2017 18:09:39 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 18:03:25 GMT]]>Obviously

]]>https://dev.proinvestor.com/forum/post/10164990https://dev.proinvestor.com/forum/post/10164990Thu, 30 Nov 2017 18:03:25 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 17:49:02 GMT]]>that is 4/5 months of data, will that be enough you think?

]]>https://dev.proinvestor.com/forum/post/10164987https://dev.proinvestor.com/forum/post/10164987Thu, 30 Nov 2017 17:49:02 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 17:45:06 GMT]]>A phase 1 which will turn into pivotal study if results are good in march/april 2018.

]]>https://dev.proinvestor.com/forum/post/10164983https://dev.proinvestor.com/forum/post/10164983Thu, 30 Nov 2017 17:45:06 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 17:36:51 GMT]]>what a machine this JNJ, testing their own Anti-PD-1 . In Belgium already recruiting. They will add more hospitals to get to 386 i would think, possibly also in US?

]]>https://dev.proinvestor.com/forum/post/10164981https://dev.proinvestor.com/forum/post/10164981Thu, 30 Nov 2017 17:36:51 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 17:35:51 GMT]]>Det var underligt Bulder. De annoncerer studiet i dag. De rekrutterer allerede og data efter 4 mdr ?

]]>https://dev.proinvestor.com/forum/post/10164980https://dev.proinvestor.com/forum/post/10164980Thu, 30 Nov 2017 17:35:51 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 17:28:06 GMT]]>NBI rykker. Nu oppe med 1.5%

]]>https://dev.proinvestor.com/forum/post/10164979https://dev.proinvestor.com/forum/post/10164979Thu, 30 Nov 2017 17:28:06 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 17:24:51 GMT]]>vedr. JnJ PD-1+dara: De regner med de fΓΈrste data allerede til marts! https://www.clinicaltrials.gov/ct2/show/study/NCT03357952?term=daratumumab+pd-1&rank=1#contacts

]]>https://dev.proinvestor.com/forum/post/10164996https://dev.proinvestor.com/forum/post/10164996Thu, 30 Nov 2017 17:24:51 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 16:42:09 GMT]]>
Access denied | www.fiercebiotech.com used Cloudflare to restrict access | www.fiercebiotech.com | Cloudflare

favicon

(www.fiercebiotech.com)

]]>https://dev.proinvestor.com/forum/post/10164978https://dev.proinvestor.com/forum/post/10164978Thu, 30 Nov 2017 16:42:09 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 16:03:42 GMT]]>Sorry....

]]>https://dev.proinvestor.com/forum/post/10164982https://dev.proinvestor.com/forum/post/10164982Thu, 30 Nov 2017 16:03:42 GMT<![CDATA[Reply to Genmab β€” November 2017 on Thu, 30 Nov 2017 16:02:49 GMT]]>Vi har stort set ikke snakket om andet hele dagen jasspinner - πŸ˜‰

]]>https://dev.proinvestor.com/forum/post/10164975https://dev.proinvestor.com/forum/post/10164975Thu, 30 Nov 2017 16:02:49 GMT